Atlas Trials

Study of Lenalidomide With Vorinostat in Pediatric Patients With High Grade or Progressive CNS Tumors

Clinical trial NCT03050450 · TERMINATED

Trial details

NCT number
NCT03050450
Sponsor
Johns Hopkins All Children's Hospital
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Central Nervous System Tumors
Start date
2016-08-10
Primary completion
2018-12-19
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.